Looking to publish in Artificial Cells Nanomedicine and Biotechnology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginArtificial Cells, Nanomedicine, and Biotechnology is an interdisciplinary journal publishing high-quality open access research at the convergence of artificial cells, nanomedicine, and health-related biotechnology. The journal emphasizes original research demonstrating game-changing and disruptive technologies, new concepts, and innovative experimental approaches, and also publishes translational work such as clinical implementation. It accepts original papers, reviews, method articles, data notes, registered reports, and editorials by invitation only, and operates a single-anonymized peer review policy.
Looking to publish in Artificial Cells Nanomedicine and Biotechnology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Artificial Cells Nanomedicine and Biotechnology accepts the following article types. Click on an article type to view submission instructions.
Original Paper
Review
Registered Report
Recent Publications
Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics
Rongjie Zhang, Ge Zhou, Jinhai Luo, Yingzi Wu, Yingjuan Huang
A scheme to tackle the dilemma from hepatoma cells under doxorubicin-resistant surroundings: a brightness or a silhouette
Ki-Kwang Oh, Goo-Hyun Kwon, Jung-A Eom, Kyeong Jin Lee, Dong Joon Kim, Ki-Tae Suk
Multiomics integrative bioinformatics analysis of gene expression characteristics and molecular mechanisms in preeclampsia placental tissue
Ni Li, Lin Tian, Haiyun Wei
Gut microbiota–nanoparticle interactions in Parkinson’s disease: mechanistic insights and therapeutic perspective
Leila Kafshdooz, Reza Safaralizadeh
Immune regulatory mechanisms and potential microbiota-associated targets in Kawasaki disease: an integrative multi-omics and network pharmacology study
Zhaojun Mei, Xiaoqin Xiong
Frequently asked questions
How long does it take to publish?
Average (median) days are tracked for submission to first decision, submission to first post-review decision, and acceptance to online publication.
Reformat to Artificial Cells Nanomedicine and Biotechnology using Livewrite PremiumWhat are the publication costs?
Open access publishing costs may be covered by a Taylor & Francis institutional open access agreement; no journal-specific APC is stated.
Reformat to Artificial Cells Nanomedicine and Biotechnology using Livewrite Premium